10-Q Filing

GLOBUS MEDICAL INC CIK: 1237831 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0001237831-14-000036`
Period End Date	20140630
Filing Date	20140806
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	gmed-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 76 Cash Flow Statement 66 Comprehensive Income 20

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$92.31M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.55M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$136.50M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.58M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$89.96M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$212.40M	USD	Point-in-time
Short-term marketable securities	`AvailableForSaleSecuritiesCurrent`	$139.76M	USD	Point-in-time
Short-term marketable securities	`AvailableForSaleSecuritiesCurrent`	$148.96M	USD	Point-in-time
Accounts receivable, net of allowances of $1,554 and $1,581, respectively	`AccountsReceivableNetCurrent`	$65.05M	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$99.91M	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$109.34M	USD	Point-in-time
Accounts receivable, net of allowances of $1,554 and $1,581, respectively	`AccountsReceivableNetCurrent`	$62.41M	USD	Point-in-time
Inventories	`InventoryNet`	$70.35M	USD	Point-in-time
Inventories	`InventoryNet`	$76.36M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.08M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.41M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	785.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	785.00M	shares	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	$2.72M	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	$4.69M	USD	Point-in-time
Deferred income taxes	`DeferredTaxAssetsNetCurrent`	$37.32M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	94.37M	shares	Point-in-time
Deferred income taxes	`DeferredTaxAssetsNetCurrent`	$39.32M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	93.44M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$416.81M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	93.44M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$467.10M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	94.37M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $109,342 and $99,910, respectively	`PropertyPlantAndEquipmentNet`	$64.15M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $109,342 and $99,910, respectively	`PropertyPlantAndEquipmentNet`	$65.57M	USD	Point-in-time
Long-term marketable securities	`AvailableForSaleSecuritiesNoncurrent`	$36.53M	USD	Point-in-time
Long-term marketable securities	`AvailableForSaleSecuritiesNoncurrent`	$36.75M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$29.54M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$29.27M	USD	Point-in-time
Goodwill	`Goodwill`	$18.37M	USD	Point-in-time
Goodwill	`Goodwill`	$18.37M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$931.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$909.00K	USD	Point-in-time
Total assets	`Assets`	$566.30M	USD	Point-in-time
Total assets	`Assets`	$618.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.07M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.81M	USD	Point-in-time
Accounts payable to related-party	`AccountsPayableRelatedPartiesCurrent`	$4.16M	USD	Point-in-time
Accounts payable to related-party	`AccountsPayableRelatedPartiesCurrent`	$2.66M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$51.37M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$51.12M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$2.36M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$212.00K	USD	Point-in-time
Business acquisition liabilities, current	`BusinessAcquisitionLiabilitiesCurrent`	$1.73M	USD	Point-in-time
Business acquisition liabilities, current	`BusinessAcquisitionLiabilitiesCurrent`	$1.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$67.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$65.97M	USD	Point-in-time
Business acquisition liabilities, net of current portion	`BusinessAcquisitionLiabilitiesNoncurrent`	$15.53M	USD	Point-in-time
Business acquisition liabilities, net of current portion	`BusinessAcquisitionLiabilitiesNoncurrent`	$15.45M	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$6.38M	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$4.15M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$4.09M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$4.12M	USD	Point-in-time
Total liabilities	`Liabilities`	$93.94M	USD	Point-in-time
Total liabilities	`Liabilities`	$89.69M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock; $0.001 par value. Authorized 785,000 shares; issued and outstanding 94,367 and 93,443 shares at June 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$94.00K	USD	Point-in-time
Common stock; $0.001 par value. Authorized 785,000 shares; issued and outstanding 94,367 and 93,443 shares at June 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$93.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$168.01M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$153.99M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.01M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-767.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-867.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.37M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$361.07M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$319.29M	USD	Point-in-time
Total equity	`StockholdersEquity`	$472.36M	USD	Point-in-time
Total equity	`StockholdersEquity`	$528.31M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$566.30M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$618.00M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Sales	`SalesRevenueNet`	$212.03M	USD	2 Qtrs
Sales	`SalesRevenueNet`	$227.78M	USD	2 Qtrs
Sales	`SalesRevenueNet`	$113.57M	USD	1 Quarter
Sales	`SalesRevenueNet`	$107.01M	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$46.99M	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$26.58M	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$51.90M	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$23.50M	USD	1 Quarter
Provision for litigation - cost of goods sold	`Provisionforlitigationlosscostofgoodssold`	-	USD	1 Quarter
Provision for litigation - cost of goods sold	`Provisionforlitigationlosscostofgoodssold`	$1.26M	USD	2 Qtrs
Provision for litigation - cost of goods sold	`Provisionforlitigationlosscostofgoodssold`	-	USD	2 Qtrs
Provision for litigation - cost of goods sold	`Provisionforlitigationlosscostofgoodssold`	$1.26M	USD	1 Quarter
Gross profit	`GrossProfit`	$175.89M	USD	2 Qtrs
Gross profit	`GrossProfit`	$82.25M	USD	1 Quarter
Gross profit	`GrossProfit`	$163.77M	USD	2 Qtrs
Gross profit	`GrossProfit`	$86.99M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$13.88M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$7.69M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$15.14M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$7.04M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$46.42M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$91.15M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$93.10M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$45.75M	USD	1 Quarter
Provision for litigation	`LossContingencyAccrualProvision`	$18.32M	USD	2 Qtrs
Provision for litigation	`LossContingencyAccrualProvision`	$3.85M	USD	2 Qtrs
Provision for litigation	`LossContingencyAccrualProvision`	$18.27M	USD	1 Quarter
Provision for litigation	`LossContingencyAccrualProvision`	$1.32M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$112.09M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$71.06M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$123.35M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$55.44M	USD	1 Quarter
Operating Income	`OperatingIncomeLoss`	$11.19M	USD	1 Quarter
Operating Income	`OperatingIncomeLoss`	$31.55M	USD	1 Quarter
Operating Income	`OperatingIncomeLoss`	$63.80M	USD	2 Qtrs
Operating Income	`OperatingIncomeLoss`	$40.42M	USD	2 Qtrs
Other income/(expense), net	`OtherNonoperatingIncomeExpense`	$-221.00K	USD	1 Quarter
Other income/(expense), net	`OtherNonoperatingIncomeExpense`	$58.00K	USD	2 Qtrs
Other income/(expense), net	`OtherNonoperatingIncomeExpense`	$570.00K	USD	2 Qtrs
Other income/(expense), net	`OtherNonoperatingIncomeExpense`	$325.00K	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$40.48M	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$10.97M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$31.88M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$64.36M	USD	2 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$13.16M	USD	2 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$11.23M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$3.54M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$22.58M	USD	2 Qtrs
Net Income	`NetIncomeLoss`	$20.65M	USD	1 Quarter
Net Income	`NetIncomeLoss`	$7.43M	USD	1 Quarter
Net Income	`NetIncomeLoss`	$27.32M	USD	2 Qtrs
Net Income	`NetIncomeLoss`	$41.79M	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.22	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.44	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.08	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.30	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.22	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.44	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.29	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.08	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	92.42M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	94.21M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	93.97M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	92.11M	shares	2 Qtrs
Dilutive stock options	`IncrementalCommonSharesAttributableToShareBasedPaymentArrangements`	1.36M	shares	2 Qtrs
Dilutive stock options	`IncrementalCommonSharesAttributableToShareBasedPaymentArrangements`	1.66M	shares	2 Qtrs
Dilutive stock options	`IncrementalCommonSharesAttributableToShareBasedPaymentArrangements`	1.27M	shares	1 Quarter
Dilutive stock options	`IncrementalCommonSharesAttributableToShareBasedPaymentArrangements`	1.55M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	93.77M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.33M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.48M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	93.97M	shares	1 Quarter
Anti-dilutive stock equivalents excluded from weighted average calculation	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	1.37M	shares	1 Quarter
Anti-dilutive stock equivalents excluded from weighted average calculation	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	1.77M	shares	1 Quarter
Anti-dilutive stock equivalents excluded from weighted average calculation	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	1.30M	shares	2 Qtrs
Anti-dilutive stock equivalents excluded from weighted average calculation	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	2.48M	shares	2 Qtrs

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$20.65M	USD	1 Quarter
Net income	`NetIncomeLoss`	$7.43M	USD	1 Quarter
Net income	`NetIncomeLoss`	$27.32M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$41.79M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$10.68M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$9.35M	USD	2 Qtrs
Amortization of premium on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-755.00K	USD	2 Qtrs
Amortization of premium on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.57M	USD	2 Qtrs
Provision for excess and obsolete inventories	`InventoryWriteDown`	$3.46M	USD	2 Qtrs
Provision for excess and obsolete inventories	`InventoryWriteDown`	$3.54M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$2.48M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$3.55M	USD	2 Qtrs
Allowance for doubtful accounts	`ProvisionForDoubtfulAccounts`	$89.00K	USD	2 Qtrs
Allowance for doubtful accounts	`ProvisionForDoubtfulAccounts`	$112.00K	USD	2 Qtrs
Change in deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-4.23M	USD	2 Qtrs
Change in deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-5.81M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$4.41M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.49M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$12.96M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$9.49M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$384.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.50M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$243.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-821.00K	USD	2 Qtrs
Accounts payable to related-party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$2.65M	USD	2 Qtrs
Accounts payable to related-party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$1.50M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$385.00K	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$15.82M	USD	2 Qtrs
Income taxes payable/receivable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-4.12M	USD	2 Qtrs
Income taxes payable/receivable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-9.24M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$27.26M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$41.58M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireInvestments`	$144.06M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireInvestments`	$105.02M	USD	2 Qtrs
Maturities of marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$3.90M	USD	2 Qtrs
Maturities of marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$95.29M	USD	2 Qtrs
Sales of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	-	USD	2 Qtrs
Sales of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	$17.16M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.23M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.96M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-153.12M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.80M	USD	2 Qtrs
Payment of business acquisition liabilities	`PaymentOfBusinessAcquisitionLiabilities`	$700.00K	USD	2 Qtrs
Payment of business acquisition liabilities	`PaymentOfBusinessAcquisitionLiabilities`	$600.00K	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$6.63M	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$4.25M	USD	2 Qtrs
Excess tax benefit related to nonqualified stock options	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$3.84M	USD	2 Qtrs
Excess tax benefit related to nonqualified stock options	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$2.19M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.87M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.74M	USD	2 Qtrs
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-117.00K	USD	2 Qtrs
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$35.00K	USD	2 Qtrs
Net increase/(decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$46.54M	USD	2 Qtrs
Net increase/(decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-120.09M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$92.31M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$136.50M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$89.96M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$212.40M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$92.31M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$136.50M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$89.96M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$212.40M	USD	Point-in-time
Interest paid	`InterestPaid`	$30.00K	USD	2 Qtrs
Interest paid	`InterestPaid`	$25.00K	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$25.89M	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$27.12M	USD	2 Qtrs

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$20.65M	USD	1 Quarter
Net income	`NetIncomeLoss`	$7.43M	USD	1 Quarter
Net income	`NetIncomeLoss`	$27.32M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$41.79M	USD	2 Qtrs
Unrealized gain/(loss) on marketable securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-59.00K	USD	2 Qtrs
Unrealized gain/(loss) on marketable securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-41.00K	USD	1 Quarter
Unrealized gain/(loss) on marketable securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$10.00K	USD	2 Qtrs
Unrealized gain/(loss) on marketable securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$9.00K	USD	1 Quarter
Foreign currency translation gain/(loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$132.00K	USD	2 Qtrs
Foreign currency translation gain/(loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$135.00K	USD	1 Quarter
Foreign currency translation gain/(loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-546.00K	USD	2 Qtrs
Foreign currency translation gain/(loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$17.00K	USD	1 Quarter
Total other comprehensive gain/(loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-24.00K	USD	1 Quarter
Total other comprehensive gain/(loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$144.00K	USD	1 Quarter
Total other comprehensive gain/(loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$142.00K	USD	2 Qtrs
Total other comprehensive gain/(loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-605.00K	USD	2 Qtrs
Comprehensive Income	`ComprehensiveIncomeNetOfTax`	$7.40M	USD	1 Quarter
Comprehensive Income	`ComprehensiveIncomeNetOfTax`	$41.93M	USD	2 Qtrs
Comprehensive Income	`ComprehensiveIncomeNetOfTax`	$20.79M	USD	1 Quarter
Comprehensive Income	`ComprehensiveIncomeNetOfTax`	$26.71M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.